4Filing Date: Jan 21, 2026

Hims & Hers Health

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001907056-26-000004
Total Value$331.9K
Trades6
Insiders1

Transaction Details

Okupe Oluyemi
Chief Financial Officer·Direct
Exercise · Acquire
Class A Common Stock
Shares+1.75K
Price$11.53
Total Value$20.2K
Shares Owned After100.68K
Transaction DateJan 20, 2026
10b5-1
Footnotes ▸

The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

Okupe Oluyemi
Chief Financial Officer·Direct
Exercise · Dispose
Stock Option (right to buy)Derivative
Shares-7.32K
Price$0.00
Total Value$0
Shares Owned After149.31K
Transaction DateJan 20, 2026
ExpiresFeb 23, 2032
10b5-1
Footnotes ▸

The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. | The Reporting Person received stock options to purchase shares of Class A Common Stock. The stock options vest over a 4-year period, with 1/48 of the shares vesting when the Reporting Person completes each month of continuous service, beginning March 24, 2022.

Okupe Oluyemi
Chief Financial Officer·Direct
Exercise · Acquire
Class A Common Stock
Shares+7.32K
Price$5.01
Total Value$36.7K
Shares Owned After98.93K
Transaction DateJan 20, 2026
10b5-1
Footnotes ▸

The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

Okupe Oluyemi
Chief Financial Officer·Direct
Sell · Dispose
Class A Common Stock
Shares-9.07K
Price$30.34
Total Value$275.1K
Shares Owned After91.62K
Transaction DateJan 20, 2026
10b5-1
Footnotes ▸

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $30.21-$30.44. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Okupe Oluyemi
Chief Financial Officer·Direct
Exercise · Dispose
Stock Option (right to buy)Derivative
Shares-1.75K
Price$0.00
Total Value$0
Shares Owned After43.00K
Transaction DateJan 20, 2026
ExpiresMar 1, 2033
10b5-1
Footnotes ▸

The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. | The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.

Okupe Oluyemi
Chief Financial Officer·Indirect · Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021
Class A Common Stock
Shares0
Price-
Total Value$0
Shares Owned After7.85K
10b5-1Holding Only

Post-Transaction Holdings

Okupe Oluyemi · Chief Financial Officer
SecuritySharesChange
Class A Common Stock108.54K-
Stock Option (right to buy)149.31K-9.07K (-5.72%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-01-20 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: Hims & Hers Health, Inc. (HIMS) CIK: 0001773751 --- Reporting Owner --- Name: Okupe Oluyemi CIK: 0001907056 Role: Officer (Chief Financial Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Class A Common Stock Date: 2026-01-20 | Code: M (Exercise of derivative) Shares: +7,317 | Price: $5.01 Total Value: $36,658.17 Shares Owned After: 98,934 | Ownership: D (Direct) Footnotes: [F1] The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. [Transaction #2] Security: Class A Common Stock Date: 2026-01-20 | Code: M (Exercise of derivative) Shares: +1,750 | Price: $11.53 Total Value: $20,177.50 Shares Owned After: 100,684 | Ownership: D (Direct) Footnotes: [F1] The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. [Transaction #3] Security: Class A Common Stock Date: 2026-01-20 | Code: S (Open market sale) Shares: -9,067 | Price: $30.34 Total Value: $275,113.63 Shares Owned After: 91,617 | Ownership: D (Direct) Footnotes: [F2] Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $30.21-$30.44. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. --- Derivative Transactions --- [Transaction #1] Security: Stock Option (right to buy) Date: 2026-01-20 | Code: M (Exercise of derivative) Shares: -7,317 | Price: $0.00 Exercisable: N/A | Expires: 2032-02-23 Shares Owned After: 149,313 | Ownership: D (Direct) Footnotes: [F1] The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. [F3] The Reporting Person received stock options to purchase shares of Class A Common Stock. The stock options vest over a 4-year period, with 1/48 of the shares vesting when the Reporting Person completes each month of continuous service, beginning March 24, 2022. [Transaction #2] Security: Stock Option (right to buy) Date: 2026-01-20 | Code: M (Exercise of derivative) Shares: -1,750 | Price: $0.00 Exercisable: N/A | Expires: 2033-03-01 Shares Owned After: 42,996 | Ownership: D (Direct) Footnotes: [F1] The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. [F4] The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023. --- Holdings --- [Holding #1] Security: Class A Common Stock Ownership: I (Indirect) --- Footnotes (Complete Index) --- F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F2: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $30.21-$30.44. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3: The Reporting Person received stock options to purchase shares of Class A Common Stock. The stock options vest over a 4-year period, with 1/48 of the shares vesting when the Reporting Person completes each month of continuous service, beginning March 24, 2022. F4: The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023. --- Signature --- /s/ /s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe (2026-01-21)

keid analysis is for reference only and does not constitute investment advice.